These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 14566208)
1. Paroxetine treatment of mood disorders in women: premenstrual dysphoric disorder and hot flashes. Yonkers KA Psychopharmacol Bull; 2003; 37 Suppl 1():135-47. PubMed ID: 14566208 [TBL] [Abstract][Full Text] [Related]
2. Six-month paroxetine treatment of premenstrual dysphoric disorder: continuous versus intermittent treatment protocols. Wu KY; Liu CY; Hsiao MC Psychiatry Clin Neurosci; 2008 Feb; 62(1):109-14. PubMed ID: 18289149 [TBL] [Abstract][Full Text] [Related]
3. In vivo neuroimaging correlates of the efficacy of paroxetine in the treatment of mood and anxiety disorders. Kilts C Psychopharmacol Bull; 2003; 37 Suppl 1():19-28. PubMed ID: 14566198 [TBL] [Abstract][Full Text] [Related]
4. Paroxetine treatment of mood and anxiety disorders in children and adolescents. Wagner KD Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of controlled-release paroxetine. Golden RN Psychopharmacol Bull; 2003; 37 Suppl 1():176-86. PubMed ID: 14566210 [TBL] [Abstract][Full Text] [Related]
6. Drug helps breast cancer survivors. Antidepressant reduces severity and frequency of hot flashes. Clin J Oncol Nurs; 2000; 4(5):199. PubMed ID: 11899761 [No Abstract] [Full Text] [Related]
7. Premenstrual exacerbations of mood disorders. Miller MN; Miller BE Psychopharmacol Bull; 2001; 35(3):135-49. PubMed ID: 12397883 [TBL] [Abstract][Full Text] [Related]
8. Mood disorders and the reproductive cycle: affective disorders during the menopause and premenstrual dysphoric disorder. Haynes P; Parry BL Psychopharmacol Bull; 1998; 34(3):313-8. PubMed ID: 9803762 [No Abstract] [Full Text] [Related]
9. Premenstrual dysphoric disorder--review of actual findings about mental disorders related to menstrual cycle and possibilities of their therapy. Zukov I; Ptácek R; Raboch J; Domluvilová D; Kuzelová H; Fischer S; Kozelek P Prague Med Rep; 2010; 111(1):12-24. PubMed ID: 20359434 [TBL] [Abstract][Full Text] [Related]
10. A drug may help hot flashes after prostate cancer treatment. Mayo Clin Health Lett; 2005 Mar; 23(3):4. PubMed ID: 15816064 [No Abstract] [Full Text] [Related]
11. A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment. Sundblad C; Wikander I; Andersch B; Eriksson E Eur Neuropsychopharmacol; 1997 Aug; 7(3):201-6. PubMed ID: 9213079 [TBL] [Abstract][Full Text] [Related]
12. New therapeutic approaches for hot flashes in women. Stearns V; Loprinzi CL J Support Oncol; 2003; 1(1):11-21; discussion 14-5, 19-21. PubMed ID: 15352639 [TBL] [Abstract][Full Text] [Related]
13. Use of antidepressants for management of hot flashes. Carroll DG; Kelley KW Pharmacotherapy; 2009 Nov; 29(11):1357-74. PubMed ID: 19857151 [TBL] [Abstract][Full Text] [Related]
14. Chronobiological basis of female-specific mood disorders. Parry BL; Newton RP Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S102-8. PubMed ID: 11682284 [TBL] [Abstract][Full Text] [Related]
15. Advancing the treatment of mood and anxiety disorders: the first 10 years' experience with paroxetine. Nemeroff CB Psychopharmacol Bull; 2003; 37 Suppl 1():6-7. PubMed ID: 14566195 [TBL] [Abstract][Full Text] [Related]
16. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents. Rapkin AJ; Mikacich JA Curr Opin Obstet Gynecol; 2008 Oct; 20(5):455-63. PubMed ID: 18797268 [TBL] [Abstract][Full Text] [Related]
18. [Therapy of affect incontinence with paroxetine]. Erfurth A Psychiatr Prax; 1997 Jul; 24(4):208-9. PubMed ID: 9340665 [No Abstract] [Full Text] [Related]
19. The association between premenstrual dysphoric disorder and other mood disorders. Yonkers KA J Clin Psychiatry; 1997; 58 Suppl 15():19-25. PubMed ID: 9427873 [TBL] [Abstract][Full Text] [Related]
20. Newer antidepressants for hot flashes--should their efficacy still be up for debate? Loprinzi CL; Barton DL; Sloan JA; Novotny PJ; Wolf S Menopause; 2009; 16(1):184-7. PubMed ID: 18725865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]